Impaired angiogenic response in the cornea of mice lacking tenascin C

Takayoshi Sumioka1, Norihito Fujita, Ai Kitano

  • 1Department of Ophthalmology, Wakayama Medical University, 811-1 Kimiidera, Wakayama, 641-0012, Japan. sumioka@wakayama-med.ac.jp

Abstract

Insights

Loss of tenascin C (TNC) suppresses vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGFβ1) expression in ocular fibroblasts, inhibiting corneal neovascularization and macrophage invasion.

Area of Science:

  • Ophthalmology
  • Cell Biology
  • Immunology

Background:

  • Neovascularization is a complex process involving the formation of new blood vessels.
  • Tenascin C (TNC) is an extracellular matrix protein implicated in various biological processes, including wound healing and inflammation.
  • Understanding the role of TNC in corneal neovascularization is crucial for developing therapeutic strategies.

Purpose of the Study:

  • To investigate the role of TNC in corneal neovascularization.
  • To elucidate the effects of TNC on the expression of vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGFβ1) in ocular fibroblasts and macrophages.

Main Methods:

  • Ocular fibroblasts and macrophages from wild-type and TNC-null mice were cultured.
  • TNC's effect on VEGF and TGFβ1 expression was assessed in vitro.
  • Corneal neovascularization was induced by cauterization in mice, and histological, immunohistochemical, and mRNA analyses were performed.

Main Results:

  • Absence of TNC suppressed VEGF expression and counteracted TGFβ1 upregulation in ocular fibroblasts.
  • TNC deficiency attenuated VEGF and TGFβ1 mRNA expression and reduced neovascularization in the cornea.
  • TNC absence inhibited macrophage, but not neutrophil, invasion into the injured cornea.

Conclusions:

  • TNC plays a significant role in regulating angiogenic gene expression in ocular fibroblasts.
  • TNC is essential for macrophage recruitment and neovascularization in the injured corneal stroma.
  • Targeting TNC may offer a therapeutic approach for managing corneal neovascularization.